Cargando…
Prediction Rules for Ruling Out Endocarditis in Patients With Staphylococcus aureus Bacteremia
BACKGROUND: Staphylococcus aureus bacteremia (SAB) is in 10% to 20% of cases complicated by infective endocarditis. Clinical prediction scores may select patients with SAB at highest risk for endocarditis, improving the diagnostic process of endocarditis. We compared the accuracy of the Prediction O...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9049276/ https://www.ncbi.nlm.nih.gov/pubmed/34272564 http://dx.doi.org/10.1093/cid/ciab632 |
_version_ | 1784696109493387264 |
---|---|
author | van der Vaart, Thomas W Prins, Jan M Soetekouw, Robin van Twillert, Gitte Veenstra, Jan Herpers, Bjorn L Rozemeijer, Wouter Jansen, Rogier R Bonten, Marc J M van der Meer, Jan T M |
author_facet | van der Vaart, Thomas W Prins, Jan M Soetekouw, Robin van Twillert, Gitte Veenstra, Jan Herpers, Bjorn L Rozemeijer, Wouter Jansen, Rogier R Bonten, Marc J M van der Meer, Jan T M |
author_sort | van der Vaart, Thomas W |
collection | PubMed |
description | BACKGROUND: Staphylococcus aureus bacteremia (SAB) is in 10% to 20% of cases complicated by infective endocarditis. Clinical prediction scores may select patients with SAB at highest risk for endocarditis, improving the diagnostic process of endocarditis. We compared the accuracy of the Prediction Of Staphylococcus aureus Infective endocarditiseTime to positivity, Iv drug use, Vascular phenomena, preExisting heart condition (POSITIVE), Predicting Risk of Endocarditis Using a Clinical Tool (PREDICT), and VIRSTA scores for classifying the likelihood of endocarditis in patients with SAB. METHODS: Between August 2017 and September 2019, we enrolled consecutive adult patients with SAB in a prospective cohort study in 7 hospitals in the Netherlands. Using the modified Duke Criteria for definite endocarditis as reference standard, sensitivity, specificity, negative predictive (NPV), and positive predictive values were determined for the POSITIVE, PREDICT, and VIRSTA scores. An NPV of at least 98% was considered safe for excluding endocarditis. RESULTS: Of 477 SAB patients enrolled, 33% had community-acquired SAB, 8% had a prosthetic valve, and 11% a cardiac implantable electronic device. Echocardiography was performed in 87% of patients, and 42% received transesophageal echocardiography (TEE). Eighty-seven (18.2%) had definite endocarditis. Sensitivity was 77.6% (65.8%–86.9%), 85.1% (75.8%–91.8%), and 98.9% (95.7%–100%) for the POSITIVE (n = 362), PREDICT, and VIRSTA scores, respectively. NPVs were 92.5% (87.9%–95.8%), 94.5% (90.7%–97.0%), and 99.3% (94.9%–100%). For the POSITIVE, PREDICT, and VIRSTA scores, 44.5%, 50.7%, and 70.9% of patients with SAB, respectively, were classified as at high risk for endocarditis. CONCLUSIONS: Only the VIRSTA score had an NPV of at least 98%, but at the expense of a high number of patients classified as high risk and thus requiring TEE. CLINICAL TRIALS REGISTRATION: Netherlands Trial Register code 6669. |
format | Online Article Text |
id | pubmed-9049276 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-90492762022-04-29 Prediction Rules for Ruling Out Endocarditis in Patients With Staphylococcus aureus Bacteremia van der Vaart, Thomas W Prins, Jan M Soetekouw, Robin van Twillert, Gitte Veenstra, Jan Herpers, Bjorn L Rozemeijer, Wouter Jansen, Rogier R Bonten, Marc J M van der Meer, Jan T M Clin Infect Dis Major Articles and Commentaries BACKGROUND: Staphylococcus aureus bacteremia (SAB) is in 10% to 20% of cases complicated by infective endocarditis. Clinical prediction scores may select patients with SAB at highest risk for endocarditis, improving the diagnostic process of endocarditis. We compared the accuracy of the Prediction Of Staphylococcus aureus Infective endocarditiseTime to positivity, Iv drug use, Vascular phenomena, preExisting heart condition (POSITIVE), Predicting Risk of Endocarditis Using a Clinical Tool (PREDICT), and VIRSTA scores for classifying the likelihood of endocarditis in patients with SAB. METHODS: Between August 2017 and September 2019, we enrolled consecutive adult patients with SAB in a prospective cohort study in 7 hospitals in the Netherlands. Using the modified Duke Criteria for definite endocarditis as reference standard, sensitivity, specificity, negative predictive (NPV), and positive predictive values were determined for the POSITIVE, PREDICT, and VIRSTA scores. An NPV of at least 98% was considered safe for excluding endocarditis. RESULTS: Of 477 SAB patients enrolled, 33% had community-acquired SAB, 8% had a prosthetic valve, and 11% a cardiac implantable electronic device. Echocardiography was performed in 87% of patients, and 42% received transesophageal echocardiography (TEE). Eighty-seven (18.2%) had definite endocarditis. Sensitivity was 77.6% (65.8%–86.9%), 85.1% (75.8%–91.8%), and 98.9% (95.7%–100%) for the POSITIVE (n = 362), PREDICT, and VIRSTA scores, respectively. NPVs were 92.5% (87.9%–95.8%), 94.5% (90.7%–97.0%), and 99.3% (94.9%–100%). For the POSITIVE, PREDICT, and VIRSTA scores, 44.5%, 50.7%, and 70.9% of patients with SAB, respectively, were classified as at high risk for endocarditis. CONCLUSIONS: Only the VIRSTA score had an NPV of at least 98%, but at the expense of a high number of patients classified as high risk and thus requiring TEE. CLINICAL TRIALS REGISTRATION: Netherlands Trial Register code 6669. Oxford University Press 2021-07-16 /pmc/articles/PMC9049276/ /pubmed/34272564 http://dx.doi.org/10.1093/cid/ciab632 Text en © The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Major Articles and Commentaries van der Vaart, Thomas W Prins, Jan M Soetekouw, Robin van Twillert, Gitte Veenstra, Jan Herpers, Bjorn L Rozemeijer, Wouter Jansen, Rogier R Bonten, Marc J M van der Meer, Jan T M Prediction Rules for Ruling Out Endocarditis in Patients With Staphylococcus aureus Bacteremia |
title | Prediction Rules for Ruling Out Endocarditis in Patients With Staphylococcus aureus Bacteremia |
title_full | Prediction Rules for Ruling Out Endocarditis in Patients With Staphylococcus aureus Bacteremia |
title_fullStr | Prediction Rules for Ruling Out Endocarditis in Patients With Staphylococcus aureus Bacteremia |
title_full_unstemmed | Prediction Rules for Ruling Out Endocarditis in Patients With Staphylococcus aureus Bacteremia |
title_short | Prediction Rules for Ruling Out Endocarditis in Patients With Staphylococcus aureus Bacteremia |
title_sort | prediction rules for ruling out endocarditis in patients with staphylococcus aureus bacteremia |
topic | Major Articles and Commentaries |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9049276/ https://www.ncbi.nlm.nih.gov/pubmed/34272564 http://dx.doi.org/10.1093/cid/ciab632 |
work_keys_str_mv | AT vandervaartthomasw predictionrulesforrulingoutendocarditisinpatientswithstaphylococcusaureusbacteremia AT prinsjanm predictionrulesforrulingoutendocarditisinpatientswithstaphylococcusaureusbacteremia AT soetekouwrobin predictionrulesforrulingoutendocarditisinpatientswithstaphylococcusaureusbacteremia AT vantwillertgitte predictionrulesforrulingoutendocarditisinpatientswithstaphylococcusaureusbacteremia AT veenstrajan predictionrulesforrulingoutendocarditisinpatientswithstaphylococcusaureusbacteremia AT herpersbjornl predictionrulesforrulingoutendocarditisinpatientswithstaphylococcusaureusbacteremia AT rozemeijerwouter predictionrulesforrulingoutendocarditisinpatientswithstaphylococcusaureusbacteremia AT jansenrogierr predictionrulesforrulingoutendocarditisinpatientswithstaphylococcusaureusbacteremia AT bontenmarcjm predictionrulesforrulingoutendocarditisinpatientswithstaphylococcusaureusbacteremia AT vandermeerjantm predictionrulesforrulingoutendocarditisinpatientswithstaphylococcusaureusbacteremia |